Demco Sprayers - 800-733-0275 - Stocking Dealer of Demco Sprayers & Parts

Demco Sprayer Video - 800-733-0275 - Stocking Demco Sprayer Dealer in USA

2012-07-22

LANCASTER COUNTY, PA, July 22, 2012 (Press-News.org) Hamilton Equipment - 800-733-0275 - is proud to be a stocking dealer of all Demco Sprayers, Booms and Parts! Call us for a price quote and specifications.

See our great action video of a Demco 150 or 200 Gallon Rear Mount Pro Series Sprayer with Jet Agitation.

Demco 150 or 200 Gallon Rear Mount Pro Series features:

150 or 200 gallon tank with jet agitation, molded sight gauge, sump, fillwell with no-splash cover.
Rear mount brackets are complete with saddles, tank bands and all necessary bolts.
Rear mount brackets will fit categories "1" and "2".
Unit may be used with a "Quick Attach" three point hookup.
Non-retractable built-in ground stand for storage when empty.
Hypro 8 roller PTO pump (C7560D) will deliver 22 GPM at 1000 RPM, 12 GPM at 540 RPM and 300 PSI max.
21', 28', 30' and 40' Truss-T booms feature vertical and horizontal boom breakaway
no drip diaphragm check nozzles spaced at 20"
Handgun with 25' of hose (optional)

Call Hamilton Equipment at 800-733-0275 for a price quote or more information. Or visit our website at www.haminc.com

ELSE PRESS RELEASES FROM THIS DATE:

TRMM sees Fabio's remnants fading in cool Pacific waters

2012-07-21

NASA's TRMM satellite noticed that Fabio's remnants have "chilled out" in very cool waters of the Eastern Pacific, while only dropping light to moderate rains. On July 18, 2012 at 2043 UTC (1:43 p.m. PDT), the Tropical Rainfall Measuring Mission (TRMM) satellite saw the remnants of what was once Hurricane Fabio southwest of the California coast. Upper level winds were shearing it apart and cool ocean waters with temperatures of about 19 Celsius (66.2 Fahrenheit) near the center of the low's circulation were chilling it at the surface. Temperatures of 26.6 C (80F) are ...

The search for medical technologies abroad

2012-07-21

Tampa, Fla. (July 19, 2012) – The search for medical technologies through 'medical travel' can change the lives of patients and their family members, according to medical anthropologists Cecilia Vindrola-Padros and Linda M. Whiteford, who examined the lives of Bolivian and Paraguayan families who traveled to Buenos Aries, Argentina, seeking pediatric oncology care for their children. In a study published in the current issue of Technology and Innovation – Proceedings of the National Academy of Inventors®, Vindrola-Padros and Whiteford, who are both at the University of ...

Beneficial bacteria may help ward off infection

2012-07-21

While many bacteria exist as aggressive pathogens, causing diseases ranging from tuberculosis and cholera, to plague, diphtheria and toxic shock syndrome, others play a less malevolent role and some are critical for human health. In a new study, Cheryl Nickerson and her group at ASU's Biodesign Institute, in collaboration with an international team* including Tom Van de Wiele and lead author Rosemarie De Weirdt at Ghent University, Belgium, explore the role of Lactobaccilus reuteri—a natural resident of the human gut—to protect against foodborne infection. Their results ...

Meta-analysis: Interventions improve depression in cancer patients

2012-07-21

Despite guidelines recommending screening for depression in cancer patients, it's been unclear whether interventions designed to treat this depression are effective. A study by the University of Colorado Cancer Center and other institutions, published in the Journal of the National Cancer Institute, changes that. This meta-analysis of 10 studies encompassing 1362 patients shows that especially cognitive behavioral therapy and pharmacologic interventions decrease depressive symptoms in cancer patients. "In the past, we had looked at interventions as a whole – most of which ...

3-D tumor models improve drug discovery success rate

2012-07-21

Imagine millions of cancer cells organized in thousands of small divots. Hit these cells with drugs and when some cells die, you have a candidate for a cancer drug. But a review published this week in the journal Expert Opinion on Drug Discovery argues that these 2D models in fact offer very little information about a potential drug's effects in the body and may often give researchers misleading results. "Up until the 1980s animal models were the standard for cancer drug discovery. However, with the increase in the number of compounds available for testing and the advent ...

Stem cell research aids understanding of cancer

2012-07-21

The study, published in the journal Stem Cell, adds to our understanding of the role of stem and next stage progenitor cells in tissue regeneration and in the diagnosis and treatment of cancer. While stem cells are known to reside in organs such as the liver and pancreas, they are difficult to isolate. The new findings show that an antibody developed by the team can be used to capture the stem cells. Professor Pera, program leader for Stem Cells Australia and Chair of Stem Cell Sciences at the University of Melbourne, said the antibody was able to detect progenitor cells ...

Research warns Asia unlikely to achieve climate, poverty goals unless women's rights are recognized

2012-07-21

BEIJING, CHINA (21 JULY 2012)—New research released today by the Rights and Resources Initiative (RRI) shows that despite more understanding, more resources, and policy recommendations, women continue to be largely marginalized and ignored or exploited in resource management processes throughout Asia – to the detriment of global climate and poverty reduction goals. This suite of analyses, released today at the International Workshop on Gender and Forest Tenure in Asia and Collective Forest Tenure Reform in China, demonstrate that exclusion and inequality on gender grounds ...

DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination

2012-07-21

On the eve of the XIX International AIDS Conference in Washington, DC, the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit research and development (R&D) organization, announces a new collaboration with Indian drug manufacturer Cipla to develop and produce an improved first-line antiretroviral (ARV) combination therapy specifically adapted to meet the treatment needs of infants and toddlers living with HIV/AIDS. Once delivered, this new pediatric ARV combination could help to accelerate the provision of care to the world's youngest children living with ...

Inaugural cross-disciplinary Public Participation in Scientific Research conference

2012-07-21

Though public participation in scientific research has deep roots in the history of science, in the last few years it has taken off spectacularly from launch pads across the disciplines of science and education, fueled by advances in communications technology and a sea change in a scientific culture now eager to welcome outsiders as collaborators. Citizen science, crowd-sourced science, DIY research, volunteer monitoring, community participatory action research – the variety of banners flying over participatory science projects reflects the diversity of their origins, ...

Cell research opens new avenues in combating neurodegenerative diseases

2012-07-21

Scientists at the University of Manchester have uncovered how the internal mechanisms in nerve cells wire the brain. The findings open up new avenues in the investigation of neurodegenerative diseases by analysing the cellular processes underlying these conditions. Dr Andreas Prokop and his team at the Faculty of Life Sciences have been studying the growth of axons, the thin cable-like extensions of nerve cells that wire the brain. If axons don't develop properly this can lead to birth disorders, mental and physical impairments and the gradual decay of brain capacity ...

Inhibition of cyclooxygenase-2 upregulates the nuclear factor erythroid 2-related factor 2 signaling pathway to mitigate hepatocyte ferroptosis in chronic liver injury

Demco Sprayers - 800-733-0275 - Stocking Dealer of Demco Sprayers & Parts

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: